TITLE

CORRECTION

PUB. DATE
January 2004
SOURCE
Nature Reviews Genetics;Jan2004, Vol. 5 Issue 1, p76
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presents a correction to the article, "Pharmacogenetics Goes Genomic," which appeared in a previous issue.
ACCESSION #
16552749

 

Related Articles

  • CORRIGENDUM: Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients.  // Clinical Pharmacology & Therapeutics;Apr2009, Vol. 85 Issue 4, p448 

    A correction to the article "Pharmacogenetics of Warfarin: Development of a Dosing Algorithm for Brazilian Patients," that was published in the August 27, 2008 is presented.

  • CORRIGENDUM: Pharmacogenetics: From Bench to Byte.  // Clinical Pharmacology & Therapeutics;Jul2008, Vol. 84 Issue 1, p175 

    A correction to the article "Pharmacogenetics: From Bench to Byte" that was published in the February 6, 2008 issue is presented.

  • Pharmacogenomics in clinical practice and drug development. Harper, Andrew R; Topol, Eric J // Nature Biotechnology;Dec2012, Vol. 30 Issue 12, p1249 

    A correction to the article "Pharmacogenomics in clinical practice and drug development," that was published in the November 8, 2012 issue is presented.

  • Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex. Haenisch, S; Zimmermann, U; Dazert, E; Wruck, C J; Dazert, P; Siegmund, S; Kroemer, H K; Warzok, R W; Cascorbi, I // Pharmacogenomics Journal;2007, Vol. 7 Issue 1, p74 

    Correction to: The Pharmacogenomics Journal 2006; doi.1038/sj.tpj.6500403. Advance online publication 20 June 2006In this article, published online 20.06.06, the authors have identified that there has been an error in the initial of one of the authors names.S Siegmund should have been W...

  • Sizingup the SNP Sector.  // PharmaGenomics;Mar/Apr2003, Vol. 3 Issue 3, p10 

    Presents information on the new report 'Pharmacogenomics: A Strategic Market Outlook and Business Analysis,' which was released by Front Line Strategic Consulting Inc. in San Mateo, California as of March 2003. Projected growth in single nucleotide polymorphism genotyping and diagnostics;...

  • Pharmacogenetic perspectives on susceptibility to toxic industrial chemicals Vesell, E. S. // British Journal of Industrial Medicine;Aug1987, Vol. 44 Issue 8, p505 

    No abstract available.

  • The Implications of Population Admixture in Race-based Drug Prescription. Suarez-Kurtz, G. // Clinical Pharmacology & Therapeutics;Mar2008, Vol. 83 Issue 3, p399 

    A letter to the editor is presented in response to the article "The ethical implications of stratifying by race in pharmacogenomics," by Lee and "Enhancing race-based prescribing prescription with pharcogenomis by Nguyen and others.

  • Complexity and Pharmacogenomics. Licinio, J.; Wong, M-L // Pharmacogenomics Journal;2002, Vol. 2 Issue 4, p203 

    Editorial. Introduces a series of articles which explores the relevance of the science of complexity to pharmacogenomics.

  • In This Issue.  // Pharmacogenomics Journal;2005, Vol. 5 Issue 3, p143 

    Introduces a series of articles about pharmacogenomics.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics